The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents

NCT00475462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2007-05-21

No results posted yet for this study

Summary

The purpose of this study to evaluate the effectiveness of metoprolol versus conventional treatment in the prevention of syncope recurrence in children and adolescents.

Conditions

  • Syncope, Vasovagal

Interventions

DRUG

metoprolol

DRUG

conventional treatment

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Junbao DU, M.D. · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Completion
2003-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00475462 on ClinicalTrials.gov